Screen of Fda-Approved Bioactive Compounds to Prime Adipose-Derived Stem Cells for Enhanced Immunomodulation and Attenuated Mitochondrial Bioenergetics in a Spontaneous Mouse Model of Metabolic Syndrome

2018-08-012024-05-18https://scholars.lib.ntu.edu.tw/handle/123456789/707648Screen of Fda-Approved Bioactive Compounds to Prime Adipose-Derived Stem Cells for Enhanced Immunomodulation and Attenuated Mitochondrial Bioenergetics in a Spontaneous Mouse Model of Metabolic Syndrome